JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A4454 Oncrasin 1

Summary: Proapoptotic agent

Soluble in DMSO
A4485 RETRA

Summary: Antitumor agent

≥31.2 mg/mL
A4530 NU 1025

Summary: PARP inhibitor,potent and novel

≥41.67 mg/mL
A8238 VX-765
13 Citation

Target: Caspases

Summary: Caspase-1 inhibitor,potent and selective

insoluble in H2O; ≥313 mg/mL
A5331 TSU-68 (SU6668,Orantinib)

Summary: PDGFR/Flk-1/FGFR1 inhibitor,potent and competitive

insoluble in EtOH; insoluble in H2O; ≥15.5 mg/mL
A5478 AZD6482

Target: PI3K

Summary: PI3Kβ inhibitor,potent and selective

insoluble in H2O; ≥20.4 mg/mL
A5793 Quizartinib (AC220)

Target: FLT3

Summary: FLT3 inhibitor,potent and selective

≥28.03 mg/mL
A8316 PD 0332991 (Palbociclib) HCl
15 Citation

Target: Cyclin-Dependent Kinases

Summary: CDK4/6 inhibitor

≥14.48 mg/mL
A8337 CX-5461
2 Citation

Summary: Pol I-mediated rRNA synthesis inhibitor

insoluble in H2O; insoluble in EtOH; insoluble in DMSO
A8374 AZD8330

Target: MEK

Summary: MEK 1/2 inhibitor

≥23.05 mg/mL